Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

eUpdate – Biliary Tract Cancer Recommendations

ESMO Clinical Practice Guideline interim update on the management of biliary tract cancer

Published online: 17 December 2024 - ESMO Open

Vogel A & Ducreux M, on behalf of the ESMO Guidelines Committee

  • This ESMO Clinical Practice Guideline update addresses new developments in the management of biliary tract cancer.
  • Recommendations are given for first-line treatment with immune checkpoint inhibitors.
  • Key recommendations are also provided for second-line treatment with targeted therapies.
  • The update also covers the latest developments in molecular testing and intra-arterial therapies.
  • A management algorithm for early-stage, locally advanced and advanced/metastatic disease is provided.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.